Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
acute lymphoblastic leukemia
Pharma
FDA OKs BMS' Breyanzi as first CAR-T for marginal zone lymphoma
With FDA approval to treat marginal zone lymphoma, BMS’ Breyanzi has become the first CAR-T therapy for the patient population.
Kevin Dunleavy
Dec 5, 2025 11:00am
Amgen gets some relief in Blincyto patent feud with Lindis
Aug 15, 2025 10:13am
Amgen's Blincyto proves its worth in pediatric leukemia study
Dec 9, 2024 11:43am
FDA approves Shorla's oral liquid version of Novartis' Gleevec
Nov 26, 2024 11:18am
For 2nd time in three months, Syndax wins FDA nod for a new drug
Nov 18, 2024 11:09am
Takeda's Iclusig wins first-line FDA nod to treat Ph+ALL
Mar 19, 2024 3:22pm
